These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 21965371)

  • 1. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
    Levy JH; Szlam F; Tanaka KA; Sniecienski RM
    Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial.
    Lancé MD; Ninivaggi M; Schols SE; Feijge MA; Oehrl SK; Kuiper GJ; Nikiforou M; Marcus MA; Hamulyak K; van Pampus EC; ten Cate H; Heemskerk JW
    Vox Sang; 2012 Jul; 103(1):25-34. PubMed ID: 22211833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.
    Levy JH; Welsby I; Goodnough LT
    Transfusion; 2014 May; 54(5):1389-405; quiz 1388. PubMed ID: 24117955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Required laboratory examination and blood transfusion therapy in massive hemorrhage during surgery].
    Yamamoto K
    Rinsho Byori; 2011 Jul; 59(7):678-83. PubMed ID: 21874794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.
    Rahe-Meyer N; Hanke A; Schmidt DS; Hagl C; Pichlmaier M
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S178-85. PubMed ID: 23410777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration.
    Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Oswald E; Bach C; Schnapka-Koepf M; Innerhofer P
    Anesth Analg; 2007 Oct; 105(4):905-17, table of contents. PubMed ID: 17898365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro efficacy of RiaSTAP after rapid reconstitution.
    Karri JV; Cardenas JC; Johansson PI; Matijevic N; Cotton BA; Wade CE; Holcomb JB
    J Surg Res; 2014 Aug; 190(2):655-61. PubMed ID: 24602482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery.
    Schols SE; Lancé MD; Feijge MA; Damoiseaux J; Marcus MA; Hamulyák K; Ten Cate H; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2010 Feb; 103(2):318-28. PubMed ID: 20024495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen as a hemostatic agent.
    Sørensen B; Larsen OH; Rea CJ; Tang M; Foley JH; Fenger-Eriksen C
    Semin Thromb Hemost; 2012 Apr; 38(3):268-73. PubMed ID: 22460909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.
    Elliott BM; Aledort LM
    Expert Rev Hematol; 2013 Jun; 6(3):277-86. PubMed ID: 23782082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit.
    Motta M; Del Vecchio A; Radicioni M
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():129-31. PubMed ID: 21942611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of thrombelastography to guide posttraumatic hemostatic therapy: More coagulation factor concentrates and less allogenic blood transfusion?].
    David JS; Imhoff E; Parat S; Augey L; Geay-Baillat MO; Incagnoli P; Tazarourte K
    Transfus Clin Biol; 2016 Nov; 23(4):205-211. PubMed ID: 27616611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood transfusion and adjunctive therapy in the bleeding trauma patient].
    Ozier Y
    Transfus Clin Biol; 2008 Nov; 15(5):240-5. PubMed ID: 18930423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryoprecipitate-topical thrombin glue. Initial experience in patients undergoing cardiac operations.
    Lupinetti FM; Stoney WS; Alford WC; Burrus GR; Glassford DM; Petracek MR; Thomas CS
    J Thorac Cardiovasc Surg; 1985 Oct; 90(4):502-5. PubMed ID: 3930885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe bleeding in surgical and trauma patients: the role of fibrinogen replacement therapy.
    Spahn DR
    Thromb Res; 2012 Dec; 130 Suppl 2():S15-9. PubMed ID: 23439002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical evaluation of cryoprecipitate for replacement of fibrinogen.
    Sørensen B; Bevan D
    Br J Haematol; 2010 Jun; 149(6):834-43. PubMed ID: 20456356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery.
    Saha SP; Muluk S; Schenk W; Burks SG; Grigorian A; Ploder B; Presch I; Pavlova BG; Hantak E
    Ann Vasc Surg; 2011 Aug; 25(6):813-22. PubMed ID: 21514114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of surgical hemostasis: systemic agents.
    Levy JH; Tanaka KA
    Vascular; 2008; 16 Suppl 1():S14-21. PubMed ID: 18544301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate.
    Schöchl H; Forster L; Woidke R; Solomon C; Voelckel W
    Anaesthesia; 2010 Feb; 65(2):199-203. PubMed ID: 19995349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.